Latanoprost+Timolol 50 micrograms/ml + 5 mg/ml Eye Drops, Solution
देश: यूनाइटेड किंगडम
भाषा: अंग्रेज़ी
स्रोत: myHealthbox
उत्पाद विशेषताएं
(SPC)
09-05-2024
इस उत्पाद के लिए कुछ दस्तावेज़ वर्तमान में उपलब्ध नहीं हैं, आप हमारी ग्राहक सेवा को अनुरोध भेज सकते हैं और जैसे ही हम उन्हें प्राप्त करने में सक्षम होंगे, हम आपको सूचित करेंगे।
अनुरोध भेजा।
अनुरोध भेजा।
सक्रिय संघटक:
Latanoprost, Timolol
थमां उपलब्ध:
Tubilux Pharma
ए.टी.सी कोड:
S01ED51
INN (इंटरनेशनल नाम):
Latanoprost, Timolol
डोज़:
50 micrograms/ml + 5 mg/ml
फार्मास्यूटिकल फॉर्म:
Eye drops
प्रशासन का मार्ग:
Eye solution use
पैकेज में यूनिट:
1 × 2.5 ml, 3 × 2.5 ml, 6 × 2.5 ml bottle
प्रिस्क्रिप्शन प्रकार:
POM - Prescription Only Medicine
द्वारा बनाया गया:
Tubilux Pharma
चिकित्सीय समूह:
Ophthalmological-betablocking agents - timolol, combinations
चिकित्सीय संकेत:
Reduction of intraocular pressure (IOP) in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.
प्राधिकरण का दर्जा:
Authorised
प्राधिकरण की तारीख:
2014-01-13
उत्पाद विशेषताएं
SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Latanoprost+Timolol 50 micrograms/ml + 5 mg/ml Eye Drops, Solution.
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml solution contains latanoprost 50 micrograms and timolol
maleate 6.8 mg
equivalent to 5 mg timolol.
Excipient: Benzalkonium chloride 0.20 mg/ml.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL
FORM
Eye drops, solution.
The solution is a clear, colourless liquid.
4 CLINICAL
PARTICULARS
4.1 THERAPEUTIC
INDICATIONS
Reduction of intraocular pressure (IOP) in patients with open angle
glaucoma and
ocular hypertension who are insufficiently responsive to topical
beta-blockers or
prostaglandin analogues.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Recommended dosage for adults (including older people):
Recommended therapy is one eye drop in the affected eye(s) once
daily.
If one dose is missed, treatment should continue with the next
dose as planned. The
dose should not exceed one drop in the affected eye(s) daily.
_ _
Method of administration:
Contact lenses should be removed before instillation of the eye
drops and may be
reinserted after 15 minutes.
When using nasolacrimal occlusion or closing the eyelids for
2 minutes, the systemic
absorption is reduced. This may result in a decrease in
systemic side effects and an
increase in local activity.
If more than one topical ophthalmic drug is being used, the drugs
should be
administered at least five minutes apart.
_ _
_Paediatric population: _
Safety and effectiveness in children and adolescents has
not been established. No data
are available.
4.3 CONTRAINDICATIONS
Latanoprost+Timolol is contraindicated in patients with:
•
Hypersensitivity to the active substances or to any of the
excipients listed in
section 6.1.
•
Reactive airway disease including
पूरा दस्तावेज़ पढ़ें
